Cancer
Credibility 80
Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe.
June 2, 2026 · South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Key takeaway
This study found that for Black women with breast cancer receiving a common chemo drug (doxorubicin), 1 in 10 experienced early heart damage, leading to significantly shorter survival. This matters because it highlights a serious side effect that impacts our health and survival.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read November 16, 2026Characterizing prior symptomatic emergency department visits among patients undergoing unplanned colon cancer surgery.Read